Published in Nucleic Acids Res on October 25, 1984
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol Cell Biol (1985) 4.94
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49
A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One (2007) 4.40
Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc Natl Acad Sci U S A (1988) 4.32
Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol (2007) 3.89
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol (1987) 3.77
Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region. Nucleic Acids Res (1985) 3.69
Genetic complementation among poliovirus mutants derived from an infectious cDNA clone. J Virol (1986) 3.65
Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol (1986) 3.59
In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus type 14. J Virol (1985) 3.19
Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol (1986) 3.15
Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol (2000) 3.14
Implications of the picornavirus capsid structure for polyprotein processing. Proc Natl Acad Sci U S A (1987) 2.99
Small nuclear inclusion protein encoded by a plant potyvirus genome is a protease. J Virol (1987) 2.77
Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J Virol (1990) 2.68
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J Virol (1993) 2.39
Relationships among the positive strand and double-strand RNA viruses as viewed through their RNA-dependent RNA polymerases. Nucleic Acids Res (1991) 2.33
The 5'-untranslated regions of picornavirus RNAs contain independent functional domains essential for RNA replication and translation. J Virol (1994) 2.32
A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol (1996) 2.29
Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J Virol (1994) 2.27
Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19
Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol (1990) 2.19
Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci (1996) 2.12
New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features. BMC Genomics (2007) 1.97
Genome-wide diversity and selective pressure in the human rhinovirus. Virol J (2007) 1.94
A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive. Proc Natl Acad Sci U S A (1986) 1.90
The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5' noncoding region of genomic RNA. J Virol (1989) 1.80
Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli. Proc Natl Acad Sci U S A (1986) 1.76
Nested PCR for specific detection and rapid identification of human picornaviruses. J Clin Microbiol (1994) 1.74
Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: identification of a cis-replicating element in the coding sequence of 2A(pro). J Virol (2001) 1.74
Isolation of a receptor protein involved in attachment of human rhinoviruses. J Virol (1986) 1.68
Sequence and organization of barley yellow dwarf virus genomic RNA. Nucleic Acids Res (1988) 1.67
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother (1999) 1.63
Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus. J Virol (1994) 1.48
Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments. J Virol (1989) 1.41
Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J Virol (1989) 1.38
Construction of poliovirus intertypic recombinants by use of cDNA. J Virol (1986) 1.38
Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J Virol (2003) 1.37
Functional dissection of a poliovirus cis-acting replication element [PV-cre(2C)]: analysis of single- and dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. J Virol (2003) 1.37
Evolutionary relationships within the human rhinovirus genus: comparison of serotypes 89, 2, and 14. Proc Natl Acad Sci U S A (1987) 1.31
Determination of the proteolytic processing sites in the polyprotein encoded by the bottom-component RNA of cowpea mosaic virus. J Virol (1986) 1.28
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother (2005) 1.25
Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol (1986) 1.23
Chimeric picornavirus polyproteins demonstrate a common 3C proteinase substrate specificity. J Virol (1989) 1.15
Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother (2000) 1.13
Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: clustering of amino acid difference identifies possible locations of immunogenic sites on the virion. Proc Natl Acad Sci U S A (1988) 1.08
A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites. EMBO J (1989) 1.08
Characterization of human rhinoviruses displaced by an anti-receptor monoclonal antibody. J Virol (1988) 1.04
Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: purification and enzymatic analysis of the RNA-dependent RNA polymerase 3D(pol). J Virol (2001) 1.00
Interaction of alphaVbeta3 and alphaVbeta6 integrins with human parechovirus 1. J Virol (2010) 0.99
Equine rhinovirus 1 is more closely related to foot-and-mouth disease virus than to other picornaviruses. Proc Natl Acad Sci U S A (1996) 0.99
In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother (2007) 0.94
Similar interactions of the poliovirus and rhinovirus 3D polymerases with the 3' untranslated region of rhinovirus 14. J Virol (1999) 0.91
Viability of poliovirus/rhinovirus VPg chimeric viruses and identification of an amino acid residue in the VPg gene critical for viral RNA replication. J Virol (2003) 0.89
Simultaneous detection and differentiation of human rhino- and enteroviruses in clinical specimens by real-time PCR with locked nucleic Acid probes. J Clin Microbiol (2013) 0.86
A generalizable DNA-catalyzed approach to peptide-nucleic acid conjugation. Chembiochem (2014) 0.84
Classification and evolution of human rhinoviruses. Methods Mol Biol (2015) 0.83
Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues. J Gen Virol (2013) 0.80
Mutations in VP1 and 3A proteins improve binding and replication of rhinovirus C15 in HeLa-E8 cells. Virology (2016) 0.79
Rapid detection and quantitation of poliovirus and rhinovirus sequences in viral stocks and infected cells. J Virol Methods (2009) 0.79
Toward an in vitro system for picornavirus assembly: purification of mengovirus 14S capsid precursor particles. J Virol (1986) 0.76
Two dimensional single-strand conformation polymorphism analysis: a useful tool for the detection of mutations in long DNA fragments. Nucleic Acids Res (1991) 0.75
Reverse genetics system for studying human rhinovirus infections. Methods Mol Biol (2015) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46
A new computer method for the storage and manipulation of DNA gel reading data. Nucleic Acids Res (1980) 36.42
Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
Random subcloning of sonicated DNA: application to shotgun DNA sequence analysis. Anal Biochem (1983) 13.88
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00
Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06
Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26
The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region. Nucleic Acids Res (1984) 4.95
On the structure of rhinovirus 1A. Virology (1971) 4.57
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Unrelated animal viruses share receptors. Nature (1976) 3.24
The complete nucleotide sequence of the RNA coding for the primary translation product of foot and mouth disease virus. Nucleic Acids Res (1984) 3.00
A comparison of the virus-specific polypeptides of encephalomyocarditis virus, human rhinovirus-1A, and poliovirus. Virology (1973) 2.50
Determination of the length distribution of poly(A) at the 3' terminus of the virion RNAs of EMC virus, poliovirus, rhinovirus, RAV-61 and CPMV and of mouse globin mRNA. Nucleic Acids Res (1979) 2.02
Rhinoviruses. Annu Rev Microbiol (1972) 1.90
Antigenic groupings of 90 rhinovirus serotypes. Infect Immun (1982) 1.73
Rhinoviruses. Yale J Biol Med (1975) 1.66
Relationship of human rhinovirus strain 2 and poliovirus as indicated by comparison of the polymerase gene regions. Virology (1984) 1.48
Taxonomy of viruses, 1980. Prog Med Virol (1980) 1.48
Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteins. Nucleic Acids Res (1983) 1.43
Molecular cloning of the genomes of poliovirus type 3 strains by the cDNA: RNA hybrid method. Arch Virol (1984) 1.22
Biophysical studies of a rhinovirus. Extraction and assay of infectious ribonucleic acid. Nature (1966) 1.19
Molecular weight of rhinovirus ribonucleic acid. J Gen Virol (1970) 1.17
Poliovirus antigenic sites and vaccines. Nature (1984) 1.15
Preliminary observations pertaining to polyadenylation of rhinovirus RNA. J Virol (1974) 1.14
Isolation of rhinovirus intertypes related to either rhinoviruses 12 and 78 or 36 and 58. Infect Immun (1983) 1.07
Lack of close relationship between three strains of human rhinoviruses as determined by their RNA sequences. J Virol (1973) 1.05
Polyadenylate sequences of human rhinovirus and poliovirus RNA and cordycepin sensitivity of virus replication. J Virol (1976) 1.01
Fragility of the rhinovirus type 14 genome to incubation at 60 degrees. Intervirology (1980) 0.92
Different patterns of polyadenylation of rhinovirus: specified RNA during multiplication in human aneuploid and diploid cells. J Gen Virol (1976) 0.85
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J (1989) 4.12
New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol (1989) 4.09
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol (1986) 3.50
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
A single gene determines the host range of influenza virus. Nature (1977) 3.43
A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A (1992) 3.28
Identification of a cis-acting replication element within the poliovirus coding region. J Virol (2000) 3.03
The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae. J Gen Virol (1987) 3.01
An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature (1989) 3.01
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Detection and differentiation of picornaviruses in clinical samples following genomic amplification. J Gen Virol (1990) 2.77
The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification. J Gen Virol (1989) 2.52
Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature (1983) 2.51
Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction. J Med Virol (1989) 2.47
Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40
Antigen chimaeras of poliovirus as potential new vaccines. Nature (1988) 2.38
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol (1987) 2.36
The smallest genome RNA segment of influenza virus contains two genes that may overlap. Proc Natl Acad Sci U S A (1979) 2.32
The 5'-untranslated regions of picornavirus RNAs contain independent functional domains essential for RNA replication and translation. J Virol (1994) 2.32
Genetic and phylogenetic clustering of enteroviruses. J Gen Virol (1996) 2.31
A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA. J Virol (1992) 2.20
Classification of enteroviruses based on molecular and biological properties. J Gen Virol (1997) 2.16
Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology (1994) 2.13
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U. Virology (1990) 2.03
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol (2000) 2.00
Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol (1986) 1.99
The 3' untranslated region of picornavirus RNA: features required for efficient genome replication. J Virol (1995) 1.96
The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev107 family of proteins involved in the control of cell proliferation. J Gen Virol (2000) 1.96
RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol (1991) 1.91
Further mapping of markers around the centromere of human chromosome 19. Genomics (1987) 1.84
Characterization of strains of type 3 poliovirus by oligonucleotide mapping. J Gen Virol (1982) 1.84
Molecular analysis of human parechovirus type 2 (formerly echovirus 23). J Gen Virol (1998) 1.84
Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro. J Virol Methods (1993) 1.82
Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J Virol (1986) 1.80
Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J Gen Virol (1989) 1.77
Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet (1982) 1.76
Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol (1987) 1.76
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J (1994) 1.76
Patterns of exon deletions in Duchenne and Becker muscular dystrophy. Hum Genet (1988) 1.73
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol (1985) 1.72
Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis (1991) 1.72
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res (1984) 1.71
The complete nucleotide sequence of coxsackievirus A21. J Gen Virol (1989) 1.70
An RNA tertiary structure in the 3' untranslated region of enteroviruses is necessary for efficient replication. J Virol (1997) 1.67
The 1st International Standard for anti-measles serum. Biologicals (1991) 1.67
The nucleotide sequence of human rhinovirus 1B: molecular relationships within the rhinovirus genus. J Gen Virol (1988) 1.67
Role for poliovirus protease 2A in cap independent translation. EMBO J (1994) 1.66
Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology (1993) 1.64
The complete nucleotide sequence of enterovirus type 70: relationships with other members of the picornaviridae. J Gen Virol (1990) 1.64
Polymerase chain reaction amplification of rhinovirus nucleic acids from clinical material. Nucleic Acids Res (1988) 1.63
The remaining stocks of smallpox virus should be destroyed. Science (1993) 1.62
Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology (1988) 1.59
Molecular relationships between 21 human rhinovirus serotypes. J Gen Virol (1995) 1.50
Comparative biochemical studies of type 3 poliovirus. J Virol (1980) 1.49
Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J Virol (1989) 1.46